This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Haemonetics Strong on Plasma & Hemostasis Management Units
by Zacks Equity Research
Haemonetics (HAE) sees encouraging growth at the North America Plasma revenues on strong disposables along with growing software revenues.
NuVasive Porous PEEK Implant OK'd for Use in XLIF Procedure
by Zacks Equity Research
NuVasive (NUVA) adopts initiatives to boost the U.S. Spinal Hardware unit.
Twitter, Marriott Vacations, Veeva, Attunity and Apptio highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Twitter, Marriott Vacations, Veeva, Attunity and Apptio highlighted as Zacks Bull and Bear of the Day
3 Cloud Stocks to Buy Right Now
by Ryan McQueeney
In a matter of just a few years, "the Cloud" has evolved from a budding new tech feature to one of the main factors driving growth in the technology sector. We've highlighted three stocks that are showing strong cloud-related activity and strong fundamental metrics. Check out these three cloud stocks to buy right now!
Veeva Systems (VEEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $89.65 in the latest trading session, marking a -0.96% move from the prior day.
Bio-Rad Clinches USDA Contract, Boosts Life Science Segment
by Zacks Equity Research
Bio-Rad (BIO) adopts initiatives to boost Life Science unit.
BD's FDA Nod for Phoenix Test Boosts Diagnostic Systems
by Zacks Equity Research
BD's (BDX) diagnostics portfolio boasts tests used for rapid susceptibility testing.
Veeva Systems (VEEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $96.63 in the latest trading session, marking a -0.54% move from the prior day.
Is Veeva Systems (VEEV) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?
Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Veeva Systems (VEEV) closed at $92.45, marking a +1.2% move from the previous day.
Veeva, Changyou, Amazon and eBay highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Veeva, Changyou, Amazon and eBay highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Veeva Systems (VEEV)
by Ryan McQueeney
This cloud stock is in the right position to grow for years.
Has Veeva Systems (VEEV) Outpaced Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Is (VEEV) Outperforming Other Computer and Technology Stocks This Year?
Veeva Launches Vault SiteDocs for Regulatory Documentation
by Zacks Equity Research
Veeva's (VEEV) Vault SiteDocs Platform conducts high-quality, compliant clinical trials with greater visibility to researchers.
Infosys (INFY) Q2 Earnings Match Estimates, Revenues Top
by Zacks Equity Research
Infosys' (INFY) second-quarter fiscal 2019 results benefit from growth across geographies and business segments.
Control4, Nine Energy, Cloudera, j2 Global and Veeva Systems highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Control4, Nine Energy, Cloudera, j2 Global and Veeva Systems highlighted as Zacks Bull and Bear of the Day
Veeva Systems (VEEV) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $90.32 in the latest trading session, marking a -1.35% move from the prior day.
3 Cloud Stocks to Buy Right Now
by Ryan McQueeney
In a matter of just a few years, "the Cloud" has evolved from a budding new tech feature to one of the main factors driving growth in the technology sector. With this in mind, we've highlighted three stocks that are showing strong cloud-related activity. Check out these three cloud stocks to buy right now!
Wright Medical (WMGI) Takes Over Cartiva for $435M in Cash
by Zacks Equity Research
The Cartiva buyout will boost Wright Medical's (WMGI) Lower Extremities business.
Medidata Cloud Manages Echocardiogram Images in WASE Study
by Zacks Equity Research
Medidata's (MDSO) Rave Imaging platform is a cloud-based clinical data management system used to electronically capture, manage and report clinical research data.
Here's Why You Should Hold CONMED Stock in Your Portfolio
by Zacks Equity Research
Despite aggressive rivalry in the MedTech space, CONMED (CNMD) to gain from its unique offerings and an extensive product portfolio.
Tyler Boosts Public Safety With New World ShieldForce Launch
by Zacks Equity Research
Tyler (TYL) unveils New World ShieldForce mobile application aimed at public safety.
Express Scripts Introduces Medicare PDP Offerings for 2019
by Zacks Equity Research
Express Scripts' (ESRX) Medicare PDP to initiate coverage from Jan 1, 2019. The plan includes Walmart along with CVS Pharmacy and the Kroger Family of Pharmacies.
Here's Why You Should Hold Ecolab Stock in Your Portfolio
by Zacks Equity Research
Despite fluctuations in the cost of raw materials, Ecolab (ECL) to gain from strong performance in the Global Industrial segment.
Allscripts (MDRX) & Appriss Health Collaborate to Fight SUD
by Zacks Equity Research
Allscripts' (MDRX) EHR solutions have lucrative prospects.